Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

230

HTML

2062

Figures (1-8)

155

Sum=2447

May 15, 2004 (publication date) through May 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. May 15, 2004; 10(10): 1409-1414
Published online May 15, 2004. doi: 10.3748/wjg.v10.i10.1409

Full Size Figure Download Figure

Figure 1 Infection efficiency of AdLacZ with different MOI.

Citation: Pan X, Wang Y, Zhang M, Pan W, Qi ZT, Cao GW. Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis. World J Gastroenterol 2004; 10(10): 1409-1414
URL: https://www.wjgnet.com/1007-9327/full/v10/i10/1409.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i10.1409